Table 3.
Major bleeding risk score
| Components of the Score | Points |
|---|---|
| Base scorea | |
| Charlson comorbidity index | |
| 2–4 | 1 |
| 5–6 | 2 |
| >6 | 3 |
| Frailty index | |
| 1.5–4.4 | 1 |
| 4.5–9.5 | 2 |
| >9.5 | 3 |
| Sex (men) | −1 |
| Dyslipidemia | −1 |
| Obesity | −1 |
| Anemia | 8 |
| Thrombocytopenia | 2 |
| Cancer within preceding years | 2 |
| Abnormal kidney function | 2 |
| Acute kidney failure | 4 |
| Glomerular disease | −1 |
| Vascular or hypertensive kidney disease | −1 |
| Diabetic kidney disease | −1 |
| Autoimmune disease | 2 |
| Vasculitis | 5 |
| Hematologic-related kidney disease | 2 |
| Thrombotic microangiopathy | 4 |
| Amyloidosis | −2 |
| Other diagnosis | −1 |
a
The major bleeding risk score was calculated as follows: base score (i.e., sum of the points for each diagnosis) + a constant of 5 points for all patients. The major bleeding score went from 0 (minimal score) to 41 (maximal score) points.